Literature DB >> 16927182

A comparison of the physical stability of amorphous felodipine and nifedipine systems.

Patrick J Marsac1, Hajime Konno, Lynne S Taylor.   

Abstract

PURPOSE: The objective of this study was to investigate thermodynamic and kinetic factors contributing to differences in the isothermal nucleation rates of two structurally related calcium channel blockers, nifedipine and felodipine, both alone and in the presence of poly(vinylpyrrolidone) (PVP).
MATERIALS AND METHODS: Thin films of amorphous systems were cast onto glass slides and the nucleation rate was determined using optical microscopy. Enthalpy, entropy, and free energy of crystallization of the pure compounds were measured using differential scanning calorimetery (DSC). Molecular mobility and glass transition temperature of each amorphous system were characterized using DSC and hydrogen bonding patterns were analyzed with infrared spectroscopy. The composition dependence of the thermodynamic activity of the amorphous drug in the presence of the polymer was estimated using Flory-Huggins lattice theory.
RESULTS: Nifedipine crystallized more readily than felodipine from the metastable amorphous form both alone and in the presence of PVP despite having a similar glass transition temperature and molecular mobility. Nifedipine was found to have a larger enthalpic driving force for crystallization and a lower activation energy for nucleation.
CONCLUSIONS: The properties of the metastable form alone did not explain the greater propensity for nifedipine crystallization. When considering the physical stability of amorphous systems, it is important to also consider the properties of the crystalline counterpart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927182     DOI: 10.1007/s11095-006-9047-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Enthalpy relaxation in binary amorphous mixtures containing sucrose.

Authors:  S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

3.  Mixing behavior of colyophilized binary systems.

Authors:  S L Shamblin; L S Taylor; G Zografi
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

4.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

6.  The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

7.  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.

Authors:  V Tantishaiyakul; N Kaewnopparat; S Ingkatawornwong
Journal:  Int J Pharm       Date:  1999-04-30       Impact factor: 5.875

8.  Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen.

Authors:  Tamaki Miyazaki; Sumie Yoshioka; Yukio Aso; Shigeo Kojima
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

9.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

Authors:  S Sethia; E Squillante
Journal:  Int J Pharm       Date:  2004-03-19       Impact factor: 5.875

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more
  22 in total

1.  Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.

Authors:  Ting Cai; Lei Zhu; Lian Yu
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

2.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.

Authors:  Shweta A Raina; Geoff G Z Zhang; David E Alonzo; Jianwei Wu; Donghua Zhu; Nathaniel D Catron; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

3.  An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.

Authors:  Sujinda Keratichewanun; Yasuo Yoshihashi; Narueporn Sutanthavibul; Katsuhide Terada; Jittima Chatchawalsaisin
Journal:  Pharm Res       Date:  2015-02-12       Impact factor: 4.200

4.  Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.

Authors:  Conor Donnelly; Yiwei Tian; Catherine Potter; David S Jones; Gavin P Andrews
Journal:  Pharm Res       Date:  2014-07-30       Impact factor: 4.200

5.  Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.

Authors:  Patrick J Marsac; Sheri L Shamblin; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

Review 6.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

Review 7.  Novel Approaches for the Treatment of Pulmonary Tuberculosis.

Authors:  Zhi Ming Tan; Gui Ping Lai; Manisha Pandey; Teerapol Srichana; Mallikarjuna Rao Pichika; Bapi Gorain; Subrat Kumar Bhattamishra; Hira Choudhury
Journal:  Pharmaceutics       Date:  2020-12-10       Impact factor: 6.321

8.  Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.

Authors:  Niraj S Trasi; Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-07-07       Impact factor: 4.200

9.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

10.  A method to evaluate the effect of contact with excipients on the surface crystallization of amorphous drugs.

Authors:  Si-Wei Zhang; Lian Yu; Jun Huang; Munir A Hussain; Lotfi Derdour; Feng Qian; Melgardt M de Villiers
Journal:  AAPS PharmSciTech       Date:  2014-07-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.